Germany’s PharmaSGP Predicts Market Turnaround Despite Difficult First Half
Executive Summary
Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.